Depression in HIV and HCV co-infected patients: a systematic review and meta-analysis (Q39093985)

9 September 2017

0 references

Depression in HIV and HCV co-infected patients: a systematic review and meta-analysis (English)

1 reference

9 September 2017

1 reference

3

1 reference

9 September 2017

Renata Fialho

1

0 references

Marco Pereira

object named as

Marco Pereira

series ordinal

2

0 references

author name string

Richard Whale

series ordinal

4

1 reference

9 September 2017

publication date

19 January 2017

1 reference

Psychology, Health and Medicine

9 September 2017

published in

1 reference

9 September 2017

volume

22

1 reference

9 September 2017

issue

9

1 reference

9 September 2017

page(s)

1089-1104

1 reference

Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Psychiatric disorders, HIV infection and HIV/hepatitis co-infection in the correctional setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Treatment of Hepatitis C in HIV-Infected Patients: Moving Towards an Era of All Oral Regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Meta-analysis of the relationship between HIV infection and risk for depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

The role of the innate immune system in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Mental disorders in HIV/HCV coinfected patients under antiviral treatment for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, France, 2006-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Depression in HIV infected patients: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Persistent inflammation in HIV infection: established concepts, new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Moderate levels of depression predict sexual transmission risk in HIV-infected MSM: a longitudinal analysis of data from six sites involved in a "prevention for positives" study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Psychosocial correlates of HIV-monoinfection and HIV/HCV-coinfection among men who have sex with men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Prevalence and correlates of emotional distress in HIV/HCV coinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Neuropsychiatric impact of hepatitis C on advanced HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Psychosocial issues and mental health treatment recommendations for patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Factors associated with risk of depression and relevant predictors of screening for depression in clinical practice: a cross-sectional study among HIV-infected individuals in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Depression and fatigue in chronic hepatitis C patients with and without HIV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Self-report and clinician-rated measures of depression severity: can one replace the other?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Psychomotor slowing in hepatitis C and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Standardization of depression measurement: a common metric was developed for 11 self-report depression measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13548506.2017.1280177

10.1080/13548506.2017.1280177

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference